St. Louis University is a clinical research site located in St Louis, Missouri, United States 63110.
Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
St. Louis University has participated in 107 clinical trials with 10 currently active.
Therapeutic areas: BCCs in Gorlin Syndrome Patients, Primary Sclerosing Cholangitis, Hepatocellular Carcinoma.
Sponsors: Palvella Therapeutics, Inc., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Exact Sciences Corporation.
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Louis University has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Louis University has 107 clinical trials on record, with 10 currently active. Their work covers BCCs in Gorlin Syndrome Patients, Primary Sclerosing Cholangitis, Hepatocellular Carcinoma.
St. Louis University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.